Anuradha Alahari (section editor)   EMA recommends revocation of authorisation for sickle cell disease medicine Adakveo OPEN framework extended to a wider range of medicines Global regulators agree on way forward to adapt COVID-19 vaccines to emerging variants Phasing out of extraordinary COVID-19 regulatory flexibilities Reflection paper on the use of artificial intelligence in the lifecycle of medicines First RSV vaccine to protect infants up to 6 months of age and older adults Medical Writing. 2023;32(3):76–80.